Sun Pharma gets China NMPA approval for ILUMETRI to treat moderate-to-severe plaque psoriasis
In China clinical studies, the PASI 75 response rate reached a high level after 28 weeks of treatment with ILUMETRI and maintained…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.